Progress in the treatment of elderly patients with primary membranous nephropathy / 中华老年医学杂志

ABSTRACT

Membranous nephropathy(MN)is the most common cause of nephrotic syndrome in the elderly.In recent years, the prevalence of MN has been increasing every year.The diagnosis and treatment of MN has entered the new era of molecular medicine with the identification of autoantibodies against the phospholipase A2 receptor(PLA2R). This review focuses on recent advances in the treatment and diagnosis of MN based on the 2020 Kidney Disease Improving Global Outcomes(KDIGO)guidelines.